Intas Pharma to acquire Udenyca business from Coherus BioSciences Ruchika Sharma4 Dec 2024 11:55 AM ISTRaleigh: Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology,...
Lupin bags Health Canada nod for biosimilar Pegfilgrastim Ruchika Sharma25 Aug 2024 2:00 PM ISTArmlupeg is available in a form of pre-filled syringe of 6mg/0.6 ml.
Aurobindo Pharma USA arm, Evive Biotech bags USFDA nod for Ryzneuta for Chemotherapy-Induced Neutropenia Ruchika Sharma22 Nov 2023 12:30 PM ISTRyzneuta is a novel long-acting Granulocyte colonystimulating factor (G-CSF), which can stimulate the proliferation, differentiation, and release of...
Short-course antibiotic therapy okay for Pseudomonas bloodstream infections in febrile neutropenia Aditi26 Oct 2023 8:00 PM ISTAntibiotic resistance, gut microbiome disturbances and adverse events have stimulated interest in revisiting standard antibiotic treatment durations....
FDA approves Rolvedon for chemotherapy induced febrile neutropenia Dr. Kamal Kant Kohli19 Sept 2022 8:00 PM ISTThe Food and Drug Administration (FDA) has approved Rolvedon (eflapegrastim-xnst) to decrease febrile neutropenia among adults with nonmyeloid...
Lupin, Biomm join hands for Pegfilgrastim distribution, marketing in Brazil Ruchika Sharma6 Dec 2021 4:03 PM ISTMumbai: Global pharma major, Lupin Limited has recently announced that the company has entered into an exclusive distribution and marketing agreement...
Procalcitonin better marker than MASCC score in patients with febrile neutropenia: Study Dr. Shravani Dali12 July 2021 9:15 AM ISTProcalcitonin (PCT) is a helpful marker with better prognostic ability than MASCC score in patients with febrile neutropenia, suggests a study...
